Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,250 across all filing types
Latest filing 2020-04-14 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
中信证券股份有限公司关于公司发行股份购买资产并募集配套资金之2019年度持续督导工作报告暨持续督导总结报告书
Audit Report / Information Classification · 95% confidence The document is titled as a "2019年度持续督导工作报告暨持续督导总结报告书" which translates to "2019 Annual Continuous Supervision Work Report and Summary Report" related to a transaction involving issuance of shares to purchase assets and raising supporting funds. It is issued by an independent financial advisor (中信证券股份有限公司) and includes detailed information about the transaction implementation, asset transfer, fundraising usage, governance structure, and compliance with laws and regulations. The document contains detailed financial data, management discussion and analysis, and audit confirmations related to the transaction and fundraising activities. It is not a full annual report (10-K) but a specialized report focusing on the continuous supervision of a major asset restructuring and fundraising transaction. This type of document is best classified as an Audit Report / Information (AR) because it is a standalone report issued by an independent financial advisor covering the audit, verification, and compliance aspects of a major asset purchase and fundraising transaction, including financial data and management analysis, but it is not a full annual report or earnings release. The document length (over 12,000 characters) and detailed content confirm it is a substantive report, not merely an announcement or certification. Therefore, the appropriate classification is AR with high confidence.
2020-04-14 Chinese
关于召开2019年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2019 Annual General Meeting (AGM) of 三诺生物传感股份有限公司. It includes information about the meeting date, voting procedures, agenda items to be discussed and voted on, registration details, and proxy forms. The document does not contain the actual annual report or financial statements but rather the notification and procedural details for the AGM. This fits the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or notices about the AGM itself. The document length is over 5,000 characters and contains comprehensive meeting details, not just a brief announcement, so it is not a Report Publication Announcement (RPA). Therefore, the correct classification is AGM Information (AGM-R).
2020-04-14 Chinese
2019年度内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Self-Evaluation Report" for the year 2019 by 三诺生物传感股份有限公司. It extensively discusses the company's internal control environment, risk assessment, control activities, information and communication, and internal supervision. It includes detailed descriptions of the company's governance structure, risk management, financial reporting controls, and internal control deficiencies and rectifications. The document is comprehensive and contains substantive content related to internal control evaluation rather than just an announcement or summary. It is not a full annual report (10-K), but rather a specialized report focusing on internal control evaluation, which aligns with the category of Audit Report / Information (AR). The length (over 13,000 characters) and detailed content confirm it is a full report, not a brief announcement or certification. Therefore, the appropriate classification is AR (Audit Report / Information).
2020-04-14 Chinese
2019年度独立董事述职报告（纪立农）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Report for the year 2019" from SanNuo Biological Sensor Co., Ltd. It details the independent director's attendance at board and shareholder meetings, opinions on major company matters, committee work, on-site inspections, and efforts to protect investor rights. The content focuses on governance, oversight, and compliance activities rather than financial results or earnings. It is a detailed report by a board member about their duties and observations during the year, which aligns with Board/Management Information filings. The document length is 3444 characters, which is relatively short but contains substantive content about board activities and independent director duties, not just an announcement or certification. Therefore, it is best classified as Board/Management Information (MANG).
2020-04-14 Chinese
2019年度董事会工作报告
Board/Management Information Classification · 95% confidence The document is titled '2019 年度董事会工作报告' which translates to '2019 Annual Board Work Report'. It contains detailed financial data such as balance sheet figures, income and profit data, and expense breakdowns for 2019 and 2018. It also discusses the board's activities, meetings, resolutions, and governance practices during the year. The content focuses on the board's work, company governance, financial performance, and future plans. There is no indication that this is a full annual report (10-K) or an earnings release (ER). Instead, it is a detailed report on the board's work and governance for the year, which fits the category of Board/Management Information (MANG). The document length (6425 characters) and detailed content support this classification rather than a brief announcement or a regulatory filing. Therefore, the document is best classified as Board/Management Information (MANG).
2020-04-14 Chinese
独立董事关于第四届董事会第四次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion report related to the fourth meeting of the fourth board of directors of the company, dated April 13, 2020. It covers various governance and compliance matters such as the 2019 profit distribution plan, related party transactions, use of raised funds, internal control self-assessment, remuneration of directors and senior management, and cash management. The document references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange, and it provides detailed independent opinions on these governance and financial oversight issues. It is not a full annual report or financial statement but rather a formal governance and board-related opinion document. This fits best under Board/Management Information (MANG), which includes announcements of board-related matters and independent directors' opinions on board meeting resolutions and governance issues. The document length is 3351 characters, which is relatively short and focused on board opinions rather than full financial disclosures or earnings. Therefore, the classification is MANG with high confidence.
2020-04-14 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.